Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

PDUFA's 'Real-World' Journey Expected To Be Slow Walk

Executive Summary

Manufacturers are enthusiastic about the possibility of using real-world evidence to expand product indications. But even with new resource support, they know it's a long road to get there.


Related Content

Woodcock's Legacy: CDER Organizational Improvements
2020 Vision For FDA's Sentinel: 'Systemic' Integration Of Surveillance Looms
Diabetes Drug Safety Might Be Best Assessed With Real-World Data
FDA To Join The 'Real World' Under PDUFA VI
FDA's Califf On Real World Evidence: 'Use It For The Right Purposes'